PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-58

  1. 2,121 Posts.
    lightbulb Created with Sketch. 568
    All talk, no action. I thought they were going to have a peer review on day 56 by now? Now they say they are going to write it?

    TGA Provisional Approval missive killed the anticipation.

    really, really sh!t
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.